Hepatitis B and C Virus Infection and Liver Cancer Risk
Author Information
Author(s): JF Tsai, JE Jeng, MS Ho, WY Chang, MY Hsieh, ZY Lin, JH Tsai
Primary Institution: Kaohsiung Medical College
Hypothesis
Is there an additive effect between chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on the development of hepatocellular carcinoma (HCC)?
Conclusion
The study found that co-infection with HBV and HCV significantly increases the risk of developing hepatocellular carcinoma.
Supporting Evidence
- 80 out of 400 patients developed HCC during the study.
- The annual incidence of HCC was 6.8% among the cohort.
- Patients co-infected with HBV and HCV had a 13.3% annual incidence of HCC.
- Patients with anti-HCV alone had a 7.0% annual incidence of HCC.
- Patients with HBsAg alone had a 6.6% annual incidence of HCC.
- Patients without either marker had a 2.0% annual incidence of HCC.
- Multivariate analysis showed that co-infection was an independent risk factor for HCC.
Takeaway
If someone has both hepatitis B and C, they are more likely to get liver cancer than if they only have one of the viruses.
Methodology
This was a prospective study following 400 cirrhotic patients for the development of HCC, with regular monitoring of liver function and viral markers.
Limitations
The study had a loss to follow-up of 10.5% of patients, which may affect the results.
Participant Demographics
The cohort consisted of 290 men and 110 women, with a mean age of 52 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI, 1.80-22.80
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website